633 related articles for article (PubMed ID: 9812525)
21. [Immune status of a school-population sample 5 years after antirubella vaccination].
Quaglio P; Dattoli A; Mantovani G
G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility to rubella and borderline immunity.
Fogel A; Barnea B; Gerichter CB
Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
[TBL] [Abstract][Full Text] [Related]
23. The immunoglobulin response to reimmunization with rubella vaccine.
Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
[TBL] [Abstract][Full Text] [Related]
24. [Antibody response to live rubella vaccination and its clinical meanings].
Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
[TBL] [Abstract][Full Text] [Related]
25. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
26. [Effect of vaccination on immune status in pregnancy].
Topolovec J
Lijec Vjesn; 1999 Mar; 121(3):73-8. PubMed ID: 10437345
[TBL] [Abstract][Full Text] [Related]
27. [Rubella vaccination using Cendehill's live virus vaccine].
Vivell O; Merschmann E; Lips G; Reiss G
Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
[No Abstract] [Full Text] [Related]
28. [Immune status against measles and rubella among 4 Chilean groups of different ages].
Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
[TBL] [Abstract][Full Text] [Related]
29. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups.
Baba K; Yabuuchi H; Okuni H; Harima R; Minekawa Y; Taniuchi M; Otsuka T; Takahashi M; Okuno Y
Biken J; 1978 Mar; 21(1):25-31. PubMed ID: 666723
[TBL] [Abstract][Full Text] [Related]
30. Rubella prevention in family practice with RA27/3 vaccine.
Hansen NH
J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
[TBL] [Abstract][Full Text] [Related]
31. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
[TBL] [Abstract][Full Text] [Related]
32. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
Leogrande G; Barnaba L; Iandolo E; Iatta E
Minerva Med; 1970 Apr; 61(30 Suppl):1595-8. PubMed ID: 4378365
[No Abstract] [Full Text] [Related]
33. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
34. Studies on live rubella vaccine. IV. Comparative field trials with attenuated vaccines at different passage levels in Japanese quail embryo fibroblast cells.
Minekawa Y; Suzuki N; Osame J; Ueda S; Yamanishi K
Biken J; 1973 Dec; 16(4):155-60. PubMed ID: 4799207
[No Abstract] [Full Text] [Related]
35. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
Hornstein L; Swartz TA; Heimann M
Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
[TBL] [Abstract][Full Text] [Related]
36. The 2001 serological survey in the Czech Republic--rubella.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S42-9. PubMed ID: 15080259
[TBL] [Abstract][Full Text] [Related]
37. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines].
Chen J
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):12-4. PubMed ID: 3995568
[No Abstract] [Full Text] [Related]
38. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
[TBL] [Abstract][Full Text] [Related]
39. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
40. Guide to the management of rubella problems.
Middleton PJ; Larke RP; Lessard P; Doran TA
Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
